Intravenous antazoline, a first‐generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio‐venous conduction and high clinical effectiveness (AntaEP Study)-Reference-Cited by-同舟云学术

Intravenous antazoline, a first‐generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio‐venous conduction and high clinical effectiveness (AntaEP Study)

Published:2019-05-23 Issue:7 Volume:85 Page:1552-1558
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Farkowski Michal M.¹^ORCID,Maciag Aleksander¹,Kowalik Ilona¹,Konka Marek²,Szwed Hanna¹,Pytkowski Mariusz¹

Affiliation:

1. Department of Coronary Artery DiseaseInstitute of Cardiology Alpejska Warsaw Poland

2. Department of Congenital Heart DiseasesInstitute of Cardiology Alpejska Warsaw Poland

Funder

Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13940

Reference27 articles.

1. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

2. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

3. Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent

4. Antazoline for termination of atrial fibrillation during the procedure of pulmonary veins isolation

5. Effect of Antazoline on Electrophysiological Properties of Atrial Muscle and Conduction System of the Heart

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of antazoline versus amiodarone, flecainide and propafenone in restoring sinus rhythm at the emergency department;Advances in Medical Sciences;2024-09

2. Randomized double-blind study comparing the efficacy and safety between antazoline and propafenone for conversion of paroxysmal atrial fibrillation to sinus rhythm (AnProAF study);Polish Archives of Internal Medicine;2024-01-02

3. Comparison of efficacy of pharmacological cardioversion with antazoline and propafenone versus electrical cardioversion in atrial fibrillation during cryoablation;Advances in Interventional Cardiology;2024

4. Effects of Inflammatory Cell Death Caused by Catheter Ablation on Atrial Fibrillation;Journal of Inflammation Research;2023-08

5. Efficacy and safety of antazoline for cardioversion of atrial fibrillation: propensity score matching analysis of multicenter registry (CANT II Study);Polish Archives of Internal Medicine;2022-03-16